{"id":"W2809024048","doi":"10.1016/j.ejca.2018.05.002","title":"Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Celgene","keywords":"Medicine; Neutropenia; Leukopenia; Rhabdomyosarcoma; Refractory (planetary science); Sarcoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Paclitaxel; Adverse effect; Chemotherapy; Progressive disease; Cancer; Gastroenterology; Surgery; Oncology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004082203,0.0002153711,0.0004957926,0.0004656078,0.00007003414,0.0000145333,0.0001297628,0.00001558331,0.00001702592],"category_scores_gemma":[0.0001108747,0.0001236731,0.00003350211,0.0012033,0.0001838416,0.0002626689,0.00002415385,0.0002379655,4.089179e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001407973,"about_ca_system_score_gemma":0.0007854932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005928862,"about_ca_topic_score_gemma":0.0004603743,"domain_scores_codex":[0.9978763,0.0002617282,0.0006614541,0.0002346593,0.0007156008,0.0002502596],"domain_scores_gemma":[0.9949976,0.00005331438,0.0012345,0.0001906207,0.003388606,0.0001353211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4120296,0.05413776,0.3655523,0.000148268,0.003917336,0.000281265,0.03046683,0.00005977742,0.004578334,0.000002345045,0.003132216,0.125694],"study_design_scores_gemma":[0.2125966,0.3727628,0.4067223,0.001041918,0.0003907291,0.0000120705,0.001901826,0.000009582815,0.004051308,0.000001261812,0.0003360407,0.0001735613],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971445,0.0006003957,0.00002857356,0.0002138454,0.00006537435,0.001436393,0.0004061066,0.000005532421,0.00009923976],"genre_scores_gemma":[0.9991655,0.0001207794,0.0002657738,0.00003521028,0.0002402841,0.00003384108,0.00001951289,0.00004904785,0.00007007783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.318625,"threshold_uncertainty_score":0.5043241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01968340602350789,"score_gpt":0.3521808022629326,"score_spread":0.3324973962394248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}